Positive News SentimentPositive NewsNASDAQ:IRON Disc Medicine (IRON) Stock Price, News & Analysis $45.67 +1.75 (+3.98%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$44.40▼$46.4350-Day Range$31.26▼$49.2352-Week Range$25.60▼$77.60Volume217,371 shsAverage Volume404,170 shsMarket Capitalization$1.13 billionP/E RatioN/ADividend YieldN/APrice Target$62.57 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Get Disc Medicine alerts: Email Address Disc Medicine MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.86 Rating ScoreUpside/Downside37.0% Upside$62.57 Price TargetShort InterestBearish10.12% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthDecreasingFrom ($4.47) to ($4.98) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.37 out of 5 starsMedical Sector559th out of 936 stocksPharmaceutical Preparations Industry253rd out of 436 stocks 4.4 Analyst's Opinion Consensus RatingDisc Medicine has received a consensus rating of Moderate Buy. The company's average rating score is 2.86, and is based on 6 buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageDisc Medicine has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Disc Medicine's stock forecast and price target. Previous Next 1.0 Short Interest Percentage of Shares Shorted10.12% of the float of Disc Medicine has been sold short.Short Interest Ratio / Days to CoverDisc Medicine has a short interest ratio ("days to cover") of 4.2.Change versus previous monthShort interest in Disc Medicine has recently increased by 3.80%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldDisc Medicine does not currently pay a dividend.Dividend GrowthDisc Medicine does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for IRON. Previous Next 2.7 News and Social Media Coverage News SentimentDisc Medicine has a news sentiment score of 1.85. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.62 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Disc Medicine this week, compared to 3 articles on an average week.Search InterestOnly 7 people have searched for IRON on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Disc Medicine to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Disc Medicine insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 4.24% of the stock of Disc Medicine is held by insiders.Percentage Held by Institutions83.70% of the stock of Disc Medicine is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Disc Medicine's insider trading history. Previous Next 0.0 Earnings and Valuation Earnings GrowthEarnings for Disc Medicine are expected to decrease in the coming year, from ($4.47) to ($4.98) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Disc Medicine is -13.51, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Disc Medicine is -13.51, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioDisc Medicine has a P/B Ratio of 3.22. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Disc Medicine's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Unstoppable Prosperity“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.You can find out what they are by clicking here now. About Disc Medicine Stock (NASDAQ:IRON)Disc Medicine, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States. The company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, primarily heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for the treatment of erythropoietic porphyrias, including erythropoietic protoporphyria, X-linked protoporphyria, and diamond-blackfan anemia; DISC-0974 for the treatment of anemia of myelofibrosis, and anemia of chronic kidney disease; and DISC-3405 for the treatment of polycythemia vera, and other hematologic disorders. The company's preclinical programs include DISC-0998, for the treatment of anemia associated with inflammatory diseases. Disc Medicine, Inc. was founded in 2017 and is headquartered in Watertown, Massachusetts.Read More IRON Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart IRON Stock News HeadlinesJuly 16, 2024 | americanbankingnews.comAnalysts Set Disc Medicine, Inc. (NASDAQ:IRON) Price Target at $62.57June 14, 2024 | seekingalpha.comDisc Medicine: Hematological Disorders Treatment Advances With DISC-0974 ProgressJuly 26, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.June 14, 2024 | globenewswire.comDisc Medicine Announces Underwritten Offering of Common StockJune 14, 2024 | globenewswire.comDisc Medicine Presents Positive Clinical Data Across Portfolio at the European Hematology Association (EHA) 2024 CongressMay 30, 2024 | globenewswire.comDisc Medicine to Participate in the Jefferies Global Healthcare ConferenceMay 15, 2024 | markets.businessinsider.comCantor Fitzgerald Keeps Their Buy Rating on Disc Medicine (IRON)May 14, 2024 | globenewswire.comDisc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2024 CongressJuly 26, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.May 13, 2024 | washingtonpost.comShould I take an iron supplement? Here’s what the science says.May 13, 2024 | globenewswire.comDisc Medicine to Participate in the H.C. Wainwright BioConnect Investor ConferenceMay 11, 2024 | finance.yahoo.comDisc Medicine Inc (IRON) Reports Q1 2024 Earnings: A Detailed Financial OverviewMay 10, 2024 | markets.businessinsider.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Electrocore (ECOR), Disc Medicine (IRON) and Allakos (ALLK)May 10, 2024 | markets.businessinsider.comOptimistic Buy Rating for Disc Medicine Amid Anticipated Study Results and Strong Financial PositionMay 9, 2024 | finanznachrichten.deDisc Medicine Inc: Disc Medicine Reports First Quarter 2024 Financial Results and Provides Business UpdateMay 9, 2024 | globenewswire.comDisc Medicine Reports First Quarter 2024 Financial Results and Provides Business UpdateMay 1, 2024 | msn.com29 incredible ancient wonders that are even older than you thinkApril 17, 2024 | msn.comDisc Medicine (IRON) Price Target Decreased by 29.78% to 58.25See More Headlines Receive IRON Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Disc Medicine and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/09/2024Today7/26/2024Next Earnings (Estimated)8/09/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:IRON CUSIPN/A CIK1816736 Webwww.discmedicine.com Phone617-401-4400FaxN/AEmployees30Year FoundedN/APrice Target and Rating Average Stock Price Target$62.57 High Stock Price Target$85.00 Low Stock Price Target$40.00 Potential Upside/Downside+37.0%Consensus RatingModerate Buy Rating Score (0-4)2.86 Research Coverage7 Analysts Profitability EPS (Most Recent Fiscal Year)($3.38) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-76,430,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-22.81% Return on Assets-21.74% Debt Debt-to-Equity RatioN/A Current Ratio23.70 Quick Ratio23.70 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$14.17 per share Price / Book3.22Miscellaneous Outstanding Shares24,720,000Free Float23,674,000Market Cap$1.13 billion OptionableNot Optionable Beta0.57 These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesDr. William Jacob Savage M.D. (Age 49)Ph.D., Chief Medical Officer Comp: $687.74kDr. John D. Quisel Esq. (Age 53)J.D., Ph.D., CEO, President & Director Comp: $750.12kDr. Brian MacDonald ChB (Age 64)MB, Ph.D., Founder & Chair of Scientific Advisory Board Comp: $88.54kMs. Jean M. Franchi (Age 58)Chief Financial Officer Mr. Jonathan Yu M.B.A. (Age 43)Chief Opearating Officer Comp: $539.32kDr. Rahul Khara J.D. (Age 42)Pharm.D., General Counsel, Compliance Officer & Secretary Mr. Srikanth Venkatraman Ph.D.Senior VP & Head of ChemistryMs. Hua Yang Ph.D.Senior Vice President of Nonclinical DevelopmentMs. Pamela Stephenson M.P.H. (Age 55)Chief Commercial Officer Ms. Sonia Razzetti Ph.D.Senior VP of QualityMore ExecutivesKey CompetitorsArdelyxNASDAQ:ARDXLiquidiaNASDAQ:LQDALandsea HomesNASDAQ:LSEACabaletta BioNASDAQ:CABAPuma BiotechnologyNASDAQ:PBYIView All CompetitorsInsiders & InstitutionsBank of New York Mellon CorpBought 24,094 shares on 7/26/2024Ownership: 0.207%SG Americas Securities LLCBought 1,247 shares on 7/12/2024Ownership: 0.016%Ikarian Capital LLCBought 396,600 shares on 5/17/2024Ownership: 0.000%Bain Capital Life Sciences Investors LLCSold 15,332 shares on 5/16/2024Ownership: 5.337%California State Teachers Retirement SystemBought 3,200 shares on 5/16/2024Ownership: 0.048%View All Insider TransactionsView All Institutional Transactions IRON Stock Analysis - Frequently Asked Questions How have IRON shares performed this year? Disc Medicine's stock was trading at $57.76 at the beginning of the year. Since then, IRON stock has decreased by 20.9% and is now trading at $45.67. View the best growth stocks for 2024 here. How were Disc Medicine's earnings last quarter? Disc Medicine, Inc. (NASDAQ:IRON) posted its quarterly earnings data on Thursday, May, 9th. The company reported ($1.09) EPS for the quarter, missing analysts' consensus estimates of ($1.00) by $0.09. Who are Disc Medicine's major shareholders? Top institutional shareholders of Disc Medicine include Bank of New York Mellon Corp (0.21%) and SG Americas Securities LLC (0.02%). Insiders that own company stock include Venture Fund X LP Atlas, Holdings A/S Novo, Orbimed Advisors Llc, Brian Richard Macdonald, Joanne Bryce, Rahul Khara, William Jacob Savage and Mona Ashiya. View institutional ownership trends. How do I buy shares of Disc Medicine? Shares of IRON stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:IRON) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Disc Medicine, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Disc Medicine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
